1,721,559 research outputs found

    Percutaneous Treatment of Cardiovascular Diseases in Women

    No full text
    Percutaneous Treatment of Cardiovascular Diseases in Wome

    Lo studio FINESSE [The FINESSE trial].

    No full text
    [The FINESSE trial]

    Difficult cases and complications from the catheterization laboratory: a case of mitral cleft

    No full text
    Percutaneous Interventions for Structural Heart Diseas

    Etiopatogenesi

    No full text

    Transcatheter Aortic Valve Replacement by trans-subclavian approach

    No full text
    Illustration of TAVR by trans-subclavian approach, in Transcatheter Aortic Valve Replacement (TAVR

    Percutaneous Valve Therapy: Choosing the Appropriate Patients and Outcomes

    No full text
    Surgical aortic valve replacement (SAVR) is the current gold standard for the treatment of severe symptomatic aortic stenosis (AS), but transcatheter aortic valve implantation (TAVI) currently represents a viable alternative to conventional SAVR for patients with AS at high risk of operative mortality. On multivariate analysis it has been shown that female gender is independently associated with better recovery of the left ventricular systolic function after TAVI and that left ventricular hypertrophy reverses more frequently in female patients after SAVR. During follow-up, however, women remain significantly more symptomatic compared with men, mainly because they present with more advanced valve disease at a significantly older age
    corecore